Efficacy of low or heavy rituximab‑based protocols and comparison with seven regimens in idiopathic membranous nephropathy: a systematic review and network meta-analysis
NefrologiaSobre o estudo
- Desenho
- Revisão sistemática
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- International urology and nephrology
- Publicado em
- 25 set 2022
- Citações
- 4
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Efficacy of low or heavy rituximab‑based protocols and comparison with seven regimens in idiopathic membranous nephropathy: a systematic review and network meta-analysis
Miaomiao Chen, Xuehan Zhang, Yi Xiong, Gaosi Xu
Descritores MeSH
- Glomerulonephritis, Membranous
- Immunosuppressive Agents
- Cyclophosphamide
- Humans
- Tacrolimus
- Cyclosporine
- Rituximab
- Treatment Outcome
- Adult
Veja também
Estudos relacionados
- Evaluating rituximab against cyclophosphamide or cyclosporine in idiopathic membranous nephropathy: a meta-analysis
- Evaluation of efficacy of rituximab for membranous nephropathy: A systematic review and meta-analysis of 11 studies
- Comparative efficacy and safety of rituximab versus cyclophosphamide with steroids in primary membranous nephropathy: a systematic review and meta-analysis
- Efficacy and safety of calcineurin inhibitor therapy in lupus nephritis: a systematic review and network meta-analysis